Company / Interest Expense per Share
Viridian Therapeutics, Inc.\DE Interest Expense per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.02
FY2022
5-year range
$0.02 / $0.02
FY2018-FY2022
Trend
-
vs FY2021
Sector context
#38 of 43
Health Care
What the data says
Viridian Therapeutics, Inc.\DE's interest expense per share of $0.02 is lower than 88% of companies in the Health Care sector (FY2022).
Based on SEC 10-K filings.
0.02 in FY2022.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.02 Sector average $18.61
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #38 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.02 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $0.13 | +259.4% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026